http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0334177-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cab64dfbe7ad218bda5bdcddbc2bf326 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 |
filingDate | 1989-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3506e09f44923084b294a18fa0739b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0405d02d89cb820d094be7ca04b1132e |
publicationDate | 1989-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0334177-A2 |
titleOfInvention | Pharmaceutical product for oral administration, particularly for the iron and magnesium substitution therapy |
abstract | The invention relates to an orally administrable pharmaceutical agent, which is particularly suitable for iron and magnesium replacement therapy. This agent consists of a combination of one or more pharmaceutically and physiologically tolerable iron compound (s), one or more pharmaceutically and physiologically tolerable magnesium compound (s) and, if the magnesium compound (s) does not contain any available chlorine atoms which saturate the available magnesium valences and are dissociable in aqueous media (Contain), one or more pharmaceutically and physiologically compatible compound (s) providing chlorine ions in aqueous media together with conventional pharmaceutical solvents and / or diluents and / or auxiliaries.n n n With this agent, it is surprisingly possible to simultaneously administer magnesium and optionally calcium compounds together with iron compounds without reducing iron absorption. |
priorityDate | 1988-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.